Kazia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	34.96	39.94	1.66	5.24	7.36	27.59
Cash & Short-Term Investments	34.96	39.94	1.66	5.24	7.36	27.59
Cash Growth	36.59%	2309.50%	-68.38%	-28.80%	-73.32%	214.78%
Accounts Receivable	7.3	4.51	3.9	3.9	0.09	0.08
Inventory	6.19	6.91	-	-	-	-
Other Current Assets	0.41	0.52	0.59	1.63	2	1.72
Total Current Assets	48.86	51.87	6.15	10.77	9.45	29.39
Net Property, Plant & Equipment	8.47	9.21	-	-	-	-
Other Intangible Assets	0.21	0.22	15.4	17.27	19.14	22
Other Long-Term Assets	0.16	0.6	0.04	0.04	7.3	6.69
Total Assets	57.7	61.9	21.59	28.09	35.89	58.09
Accounts Payable	4.68	4.28	15.07	4.33	3.76	4.93
Accrued Expenses	-	-	0.36	0.69	0.37	0.23
Short-Term Debt	0.68	0.85	-	-	-	-
Current Portion of Long-Term Debt	-	-	0.63	1.8	1.84	-
Other Current Liabilities	0.32	0.28	9.73	0.75	0.76	3.17
Total Current Liabilities	5.68	5.4	25.8	7.57	6.73	8.33
Long-Term Debt	1.95	2.29	-	-	-	-
Other Long-Term Liabilities	0.19	0.16	5.81	8.47	10.89	11.91
Total Long-Term Liabilities	2.14	2.45	5.81	8.47	10.89	11.91
Total Liabilities	7.82	7.86	31.6	16.03	17.61	20.24
Common Stock	137.31	137.25	101.64	97.45	84.48	80.29
Additional Paid-in Capital	-	-	-	-	-	0.46
Accumulated Other Comprehensive Income	0.01	-	3.47	3.68	2.41	1.3
Retained Earnings	-88.09	-83.97	-115.13	-89.08	-68.62	-44.2
Total Common Shareholders' Equity	49.23	53.28	-10.02	12.05	18.28	37.85
Minority Interest	0.66	0.77	-	-	-	-
Shareholders' Equity	49.89	54.05	-10.02	12.05	18.28	37.85
Total Liabilities & Equity	57.7	61.9	21.59	28.09	35.89	58.09
Total Debt	1.76	2.06	0.42	1.2	1.27	0
Net Cash (Debt)	21.56	24.2	0.68	2.3	3.81	20.68
Net Cash Growth	-10.92%	3444.16%	-70.25%	-39.72%	-81.59%	242.06%
Net Cash Per Share	112.98	22.09	1.29	6.23	14.37	87.89
Book Value	32.84	35.04	-6.69	8.03	12.61	28.38
Book Value Per Share	172.06	31.97	-12.68	21.78	47.58	120.59
Tangible Book Value	32.7	34.89	-16.96	-3.48	-0.6	11.88
Tangible Book Value Per Share	171.34	31.84	-32.17	-9.43	-2.25	50.49

SEC Filings: 10-K · 10-Q